RVTY Stock Summary and Trading Ideas (Revvity | NYSE:RVTY)

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity trades on the NYSE stock market under the symbol RVTY.

As of March 4, 2025, RVTY stock price declined to $109.26 with 880,980 million shares trading.

RVTY has a beta of 0.65, meaning it tends to be less sensitive to market movements. RVTY has a correlation of 0.11 to the broad based SPY ETF.

RVTY has a market cap of $13.13 billion. This is considered a Large Cap stock.

Last quarter Revvity reported $729 million in Revenue and $1.42 earnings per share. This fell short of revenue expectation by $-698,000 and exceeded earnings estimates by $.04.

The top ETF exchange traded funds that RVTY belongs to (by Net Assets): VTI, VOO, VB, SPY, VO.

RVTY has underperformed the market in the last year with a return of +2.3%, while the SPY ETF gained +13.9%. In the last 3 month period, RVTY fell short of the market, returning -4.9%, while SPY returned -4.2%. However, in the most recent 2 weeks RVTY has outperformed the stock market by returning -2.7%, while SPY returned -5.4%.

RVTY support price is $108.26 and resistance is $112.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RVTY shares will trade within this expected range on the day.